NO20076040L - Nye laktam-sammensetninger - Google Patents

Nye laktam-sammensetninger

Info

Publication number: NO20076040L
Authority: NO; Norway
Prior art keywords: diabetic; new lactam; present; provides; new
Prior art date: 2005-04-28

Application number

NO20076040A

Other languages

English (en)

Norwegian (no)

Inventor

Itsuya Tanabe

Hideyuki Tanaka

Wataru Miyanaga

Masaru Takayanagi

Ryusuke Hirama

Yoko Kageyama

Tatsuya Ishikawa

Yoriko Okamatsu

Original Assignee

Ajinomoto Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-28

Filing date

2007-11-23

Publication date

2008-01-28

2007-11-23 Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk

2008-01-28 Publication of NO20076040L publication Critical patent/NO20076040L/no

Links

150000003951 lactams Chemical class 0.000 title 1
239000000203 mixture Substances 0.000 title 1
206010012601 diabetes mellitus Diseases 0.000 abstract 2
-1 lactam compounds Chemical class 0.000 abstract 2
208000007342 Diabetic Nephropathies Diseases 0.000 abstract 1
208000032131 Diabetic Neuropathies Diseases 0.000 abstract 1
206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000033679 diabetic kidney disease Diseases 0.000 abstract 1
239000003623 enhancer Substances 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Neurology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyrrole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20076040A 2005-04-28 2007-11-23 Nye laktam-sammensetninger NO20076040L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005130879		2005-04-28
PCT/JP2006/309349 WO2006118341A1 (ja)	2005-04-28	2006-04-28	新規ラクタム化合物

Publications (1)

Publication Number	Publication Date
NO20076040L true NO20076040L (no)	2008-01-28

Family

ID=37308118

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20076040A NO20076040L (no)	2005-04-28	2007-11-23	Nye laktam-sammensetninger

Country Status (14)

Country	Link
US (1)	US7951799B2 (pt)
EP (1)	EP1878734A4 (pt)
JP (1)	JP5056412B2 (pt)
KR (1)	KR20080004632A (pt)
CN (1)	CN101166742B (pt)
AU (1)	AU2006241684A1 (pt)
BR (1)	BRPI0610034A2 (pt)
CA (1)	CA2607506A1 (pt)
IL (1)	IL186972A0 (pt)
NO (1)	NO20076040L (pt)
NZ (2)	NZ563131A (pt)
RU (1)	RU2007144076A (pt)
WO (1)	WO2006118341A1 (pt)
ZA (1)	ZA200709235B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005042536A1 (ja) *	2003-10-31	2005-05-12	Ajinomoto Co., Inc.	複素環を有する新規縮合多環式化合物及びその医薬用途
JP5672699B2 (ja) *	2007-04-11	2015-02-18	味の素株式会社	血糖降下作用化合物のスクリーニング法
WO2008136394A1 (ja) *	2007-04-27	2008-11-13	Ajinomoto Co., Inc.	ラクタム化合物の製造方法及びその製造中間体
WO2008139574A1 (ja) *	2007-04-27	2008-11-20	Ajinomoto Co., Inc.	ラクタム化合物の結晶形およびその製造方法
WO2008139576A1 (ja) *	2007-04-27	2008-11-20	Ajinomoto Co., Inc.	ラクタム化合物の製造方法及びその製造中間体
JP2012180283A (ja) *	2009-07-02	2012-09-20	Ajinomoto Co Inc	ラクタム化合物の製造方法およびその製造中間体
JP2012180282A (ja) *	2009-07-02	2012-09-20	Ajinomoto Co Inc	ラクタム化合物の製造方法およびその製造中間体
LT2661266T (lt)	2011-01-07	2020-12-10	Anji Pharma (Us) Llc	Gydimo būdai chemosensorinio receptoriaus ligando pagrindu
US9795792B2 (en)	2011-02-25	2017-10-24	Medtronic, Inc.	Emergency mode switching for non-pacing modes
CN104254325A (zh)	2012-01-06	2014-12-31	埃尔舍利克斯治疗公司	双胍组合物和治疗代谢性病症的方法
CN110693867A (zh)	2012-01-06	2020-01-17	埃尔舍利克斯治疗公司	用于治疗代谢性病症的组合物和方法
CA2878625A1 (en)	2012-07-11	2014-01-16	Elcelyx Therapeutics, Inc.	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
HK1214966A1 (zh)	2013-01-05	2016-08-12	Anji Pharmaceuticals Inc.	包含雙胍的延遲釋放組合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI234557B (en)	1999-05-26	2005-06-21	Telik Inc	Novel naphthalene ureas as glucose uptake enhancers
US7067520B2 (en)	2000-11-17	2006-06-27	Ishihara Sangyo Kaisha, Ltd.	Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts
JP3826400B2 (ja) *	2000-12-01	2006-09-27	味の素株式会社	ラクタム化合物及びその医薬用途
JP4345097B2 (ja) *	2002-06-05	2009-10-14	味の素株式会社	縮合多環式化合物およびその医薬用途
RU2358738C2 (ru) *	2003-02-07	2009-06-20	Адзиномото Ко., Инк.	Лекарственные средства для лечения сахарного диабета
WO2005042536A1 (ja) *	2003-10-31	2005-05-12	Ajinomoto Co., Inc.	複素環を有する新規縮合多環式化合物及びその医薬用途
JPWO2005068467A1 (ja) *	2004-01-14	2007-12-27	味の素株式会社	新規縮環化合物

2006
- 2006-04-28 WO PCT/JP2006/309349 patent/WO2006118341A1/ja not_active Ceased
- 2006-04-28 NZ NZ563131A patent/NZ563131A/en unknown
- 2006-04-28 NZ NZ587672A patent/NZ587672A/en unknown
- 2006-04-28 BR BRPI0610034-1A patent/BRPI0610034A2/pt not_active IP Right Cessation
- 2006-04-28 RU RU2007144076/04A patent/RU2007144076A/ru not_active Application Discontinuation
- 2006-04-28 AU AU2006241684A patent/AU2006241684A1/en not_active Abandoned
- 2006-04-28 ZA ZA200709235A patent/ZA200709235B/xx unknown
- 2006-04-28 KR KR1020077027532A patent/KR20080004632A/ko not_active Withdrawn
- 2006-04-28 CN CN2006800142330A patent/CN101166742B/zh not_active Expired - Fee Related
- 2006-04-28 EP EP06746180A patent/EP1878734A4/en not_active Withdrawn
- 2006-04-28 CA CA002607506A patent/CA2607506A1/en not_active Abandoned
- 2006-04-28 JP JP2007514876A patent/JP5056412B2/ja not_active Expired - Fee Related
2007
- 2007-10-28 IL IL186972A patent/IL186972A0/en unknown
- 2007-10-29 US US11/926,745 patent/US7951799B2/en not_active Expired - Fee Related
- 2007-11-23 NO NO20076040A patent/NO20076040L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20080108604A1 (en)	2008-05-08
RU2007144076A (ru)	2009-06-10
CA2607506A1 (en)	2006-11-09
KR20080004632A (ko)	2008-01-09
US7951799B2 (en)	2011-05-31
CN101166742B (zh)	2011-07-13
CN101166742A (zh)	2008-04-23
NZ563131A (en)	2010-09-30
IL186972A0 (en)	2008-02-09
BRPI0610034A2 (pt)	2011-10-18
EP1878734A4 (en)	2010-02-17
EP1878734A1 (en)	2008-01-16
WO2006118341A1 (ja)	2006-11-09
ZA200709235B (en)	2009-09-30
JP5056412B2 (ja)	2012-10-24
NZ587672A (en)	2011-12-22
JPWO2006118341A1 (ja)	2008-12-18
AU2006241684A1 (en)	2006-11-09

Legal Events

Date	Code	Title	Description
2011-11-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20076040L (no)	2008-01-28	Nye laktam-sammensetninger
Huigens et al.	2007	Inhibition of Pseudomonas aeruginosa biofilm formation with bromoageliferin analogues
NO20074012L (no)	2007-10-08	1-tio-D-glucitolderivater
WO2007041365A3 (en)	2007-06-21	3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
NO20051585L (no)	2005-06-20	Stabilized exendin-4 compounds
NO20084874L (no)	2008-11-19	Piendinylsubstituerte pyrrolidinoner som hemmere av 11-beta-hydroksysteroiddehydrogenase 1
NO20055680L (no)	2006-01-11	Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
EA201100266A1 (ru)	2011-10-31	Диокса-бицикло[3.2.1]октан-2,3,4-триольные производные
NO20065926L (no)	2007-02-12	Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav
TNSN06030A1 (en)	2007-10-03	Substituted thiazole-benzoisothiazole dioxide derivavites, method for the production thereof and use of the same
NO20085056L (no)	2008-12-03	Insulinderivat
IL186566A0 (en)	2008-01-20	Substituted 2-amin0alkylth10-benzimidaz0les and use thereof for reducing blood sugar levels
NO20084318L (no)	2008-10-15	Inhibitorer av II-beta-hydroksystereoid dehydrogenase I
TNSN06315A1 (en)	2007-12-03	Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes
NO20056010L (no)	2006-01-20	Biaryloksymetylaren-karboksylsyrer
WO2008051272A3 (en)	2008-06-12	Somatostatin agonists
WO2006099943A8 (de)	2006-11-09	Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO20070487L (no)	2007-03-05	3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20084364L (no)	2008-10-31	Azetidin derivater som G-protein koblet reseptor (GPR119) agonister
WO2006099941A8 (de)	2006-11-09	Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO20076638L (no)	2007-12-21	Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
NO20092691L (no)	2009-09-16	4-hydroksy-2-okso-2,3-dihydro-1,3-benzotiazol-7yl-forbindelser for modulering av B2-adrenoreseptoraktivitet
NO20050932L (no)	2005-04-15	1-pyridin-4-yl-ureaderivater
NO20083065L (no)	2008-09-04	Nye N-sulfamoylpiperidinamider for profylakse eller behandling av overvekt og beslektede tilstander
WO2007065808A3 (en)	2007-08-02	Neuropeptide-2 receptor-agonists